- Company Overview for GLIDE PHARMACEUTICAL TECHNOLOGIES LIMITED (04173789)
- Filing history for GLIDE PHARMACEUTICAL TECHNOLOGIES LIMITED (04173789)
- People for GLIDE PHARMACEUTICAL TECHNOLOGIES LIMITED (04173789)
- Charges for GLIDE PHARMACEUTICAL TECHNOLOGIES LIMITED (04173789)
- Insolvency for GLIDE PHARMACEUTICAL TECHNOLOGIES LIMITED (04173789)
- More for GLIDE PHARMACEUTICAL TECHNOLOGIES LIMITED (04173789)
Persons with significant control: 2 persons with significant control / 0 statements
Mr Anthony Rowlands
- Correspondence address
- Rsm Restructuring Advisory Llp, 3 Hardman Street, Manchester, M3 3HF
- Notified on
- 20 January 2017
- Date of birth
- June 1956
- Nationality
- British
- Country of residence
- Monaco
- Nature of control
- Has significant influence or control
Bank Of New York (Nominees) Limited
- Correspondence address
- 160 Queen Victoria Street, London, England, EC4V 4LA
- Notified on
- 6 April 2016
- Governing law
- Legal form
- Rle
- Place registered
- Companies House
- Registration number
- 00928736
- Incorporated in
- England & Wales
- Nature of control
- Ownership of voting rights - More than 25% but not more than 50%
- Right to appoint or remove directors